Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception.
The effect of oral contraceptive therapy was studied in five patients with homozygous activated protein C resistance. Patients with this congenital abnormality, in contrast to those with antithrombin, protein C or protein S deficiencies, showed only a mild thrombotic tendency. In fact, only two of six observations (one patient took the pill on two separate occasions many years apart) showed deep vein thrombosis. No patient had pulmonary embolism. Two additional patients had a superficial vein thrombosis of the legs. In two instances, a superficial vein thrombosis and a deep vein thrombosis, concomitant risk factors were present (immobilization and surgery for an ovarian cyst, respectively). However, compared with heterozygous for the same abnormality, the symptomatic homozygous patients with APC resistance appeared to develop thrombosis after a shorter period of oral contraception.
Institute of Medical Semiotics, University of Padua Medical School, Italy.
A
A
Girolami
P
P
Simioni
B
B
Girolami
P
P
Radossi
D000328:Adult; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral / Q000009:adverse effects*; D006720:Homozygote; D006801:Humans; D011486:Protein C / Q000235:genetics / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism*; D013924:Thrombophlebitis / Q000209:etiology*
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D011486:Protein C; D011956:Receptors, Cell Surface; C091963:activated protein C receptor